Intergenotypic variation of endothelial dysfunction and inflammatory markers in eclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Immunology

Background:

• Eclampsia involves cytokine imbalance and endothelial dysfunction, with nitric oxide (NO) synthases playing a potential role.
• Endothelial NO synthase (eNOS) gene polymorphism may influence cytokine production and endothelial function.
• The study investigates if eNOS Glu298Asp gene polymorphism contributes to endothelial dysfunction in eclampsia via impaired NO production and cytokine activity.

Purpose of the Study:

• To test the hypothesis that inflammatory cytokines impair endothelium-dependent relaxation.
• To determine if NO production is vitiated due to eNOS Glu298Asp gene polymorphism in eclampsia.
• To explore the relationship between genetic factors, inflammation, and endothelial dysfunction in eclampsia.

Main Methods:

• A cross-sectional study involving 100 women with eclampsia and 100 healthy pregnant women.
• Analysis of blood samples for NO metabolites and inflammatory cytokines (TNF-α, IL-2, IL-6, IFN-γ).
• Determination of eNOS (Glu298Asp) gene polymorphism using DNA extraction and restriction fragment length polymorphism.

Main Results:

• Eclamptic women showed decreased NO metabolites and elevated cytokine levels (p < 0.001).
• Significant differences in genotype/allele distribution of eNOS Glu298Asp were observed between groups.
• A negative correlation was found between NO levels and specific cytokines (TNF-α, IFN-γ) in eclamptic women (p = 0.001).

Conclusions:

• Eclampsia is associated with reduced NO levels and increased circulating inflammatory cytokines.
• Single-nucleotide polymorphism in the eNOS gene may contribute to these alterations.
• Findings highlight the roles of endothelial dysfunction and inflammatory processes in eclampsia pathogenesis.